*** News alert: my memoir written with Garry Maddox is coming out soon*** Just over a year ago I was diagnosed with a Grade 4 IDH wildtype glioblastoma – the worst subtype of brain cancer. I am now patient zero for applying melanoma science to treatment for my cancer.

It’s pretty archaic when folks charge 2-3% fees for using a credit card. You wonder why people gravitate towards crypto.

Pretty much true.

This is it. See Ian Katz post. Better summary. 👇🏼

A lot of young leaders think that the point of their job is to keep everyone on their team happy, when in fact, it’s to keep the best people on their team happy. And allow the rest to rise to the occasion or weed themselves out. Yes - that means low performers will whine. It

For all the non-believers in. Nested and DN-like melanomas, another data point to help you believe.

Is ChatGPT correct?

Predictions are impossible but one should at least get educated on #BTC. $SMLR is also a great company and their board is forward thinking. Eric Semler

Dream: When you do what you love, you never work again a day in your life. Reality: When you do what you love, you get moments you love punctuated by long periods of pain.

You have to go through moments of doubt, pain, and hate to get to anew mountain top of anything you love. Agree with this logic.

Science is not a business. True breakthrough discoveries involve trial and error, serendipity, and an environment that allows some element of risk. Monetizing ROI is for the private sector. I learned decades ago that you never know where those big impactful discoveries come from

I read this article and would hire phone communicators any day of the week. The “Communication Differences” section is problematic. It’s how our group stands out. In fact, talk on the phone more. Sure, we all love digital communication but talking wins. doximity.com/newsfeed/6a244…

Problem is indeterminate results arise often for both benign and malignant lesions (overlap). I actually think a real world analysis should do something with those numbers: with and without. pubmed.ncbi.nlm.nih.gov/39141759/

a great response. Also, “Standards for Reporting of Diagnostic Accuracy Studies (STARD)” sounds a little suspect. journals.lww.com/amjdermatopath…